. Author manuscript; available in PMC: 2022 May 14.

Published in final edited form as: Blood Cells Mol Dis. 2021 Jan 6;88:102536. doi: 10.1016/j.bcmd.2021.102536

Table 2.

Features and findings among study-neonates treated with darbepoetin.

No.	Birth wt (g)	GA @ Birth (w/d)	Sex	Mother BMI	Postnatal age at Darbe dose (d)	Iron dosing before Darbe?	Darbe dose given (date/time)	Post-Darbe blood draw (date/time)	Interval between Darbe and blood draw (h)	Pre-Darbe Hgb (g/dL)	Pre-Darbe RET-He (pg)	Pre-Darbe ERFE (ng/mL)	Post-Darbe ERFE (ng/mL)	Pre-Darbe Hepcidin (ng/mL)	Post-Darbe Hepcidin (ng/mL)

1	995	27 0	F	25.3	53	Yes	1/28/20 15:06	2/3/20 12:10	141	1/21/20 12.6	1/21/20 29.1	0.9	0.4	6.6	8.2
2	930	25 1	M	35.5	14	Yes	1/28/20 16:29	1/31/20 04:20	60	1/28/20 13.3	1/27/20 25.0	0.4	1.5	69.8	48.8
3	1050	30 3	F	57.0	1	No	1/28/20 16:29	1/31/20 04:20	60	1/27/20 16.5	–	3.4	2.1	6.6	12.6
4	945	25 3	F	34.4	21	Yes	2/4/20 13:08	2/6/20 04:00	39	2/6/20 13.1	2/3/20 25.6	0.3	0.4	212.5	167.1
5	1460	29 5	F	22.6	0	No	2/6/20 15:07	2/9/20 05:00	62	2/6/20 15.7	–	0.2	0.3	125.0	47.4
6	1335	28 5	F	34.8	26	Yes	2/11/20 14:20	2/14/20 08:55	66	–	2/10/20 24.3	0.4	1.5	7.3	7.2
7	605	23 6	F	26.8	47	Yes	2/17/20 14:51	2/18/20 19:11	29	2/14/20 11.6	–	0.2	0.3	29.9	14.1
8	690	23 6	M	26.8	47	Yes	2/17/20 15:33	2/18/20 07:16	16	2/18/20 10.3	–	0.2	0.4	17.9	52.7^a
9	610	23 6	F	26.8	47	Yes	2/17/20 16:02	2/19/20 04:00	36	2/19/20 11.1	–	0.1	0.2	26.0	19.8
10	945	25 3	F	34.4	42	Yes	2/25/20 14:00	2/26/20 05:20	15	2/24/20 12.8	2/10/20 31.7	0.3	0.5	178.7	88.6

No., number; Wt, weight; g, grams; GA, gestational age; w, weeks; d, days; h, hours; Hgb, hemoglobin.

Pneumonia developed between pre- and post-darbe phlebotomy (FiO₂ increased to 100%, ventilator settings increased, x-ray consistent with pneumonia).